Back

argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 24 apr 2018 - 07:00
  • Statutory name argenx SE
  • Title argenx to present complete data from the Phase 2 proof-of-concept trial of efgartigimod (ARGX-113) in

Related downloads

201804240000000001_argenx to present complete data from the Phase 2 proof-of-concept trial of efgartigimod (ARGX-113) in.pdf

Date last update: 21 November 2018

Share information

Share on: Share this